Gastroenterology
Volume 123, Issue 6 , Pages 1778-1785, December 2002

Long-term improvement in functional dyspepsia using hypnotherapy☆☆

Received 3 May 2002; accepted 27 August 2002.

Abstract 

Background & Aims: We have shown hypnotherapy (HT) to be effective in irritable bowel syndrome, with long-term improvements in symptomatology and quality of life (QOL). This study aimed to assess the efficacy of HT in functional dyspepsia (FD). Methods: A total of 126 FD patients were randomized to HT, supportive therapy plus placebo medication, or medical treatment for 16 weeks. Percentage change in symptomatology from baseline was assessed after the 16-week treatment phase (short-term) and after 56 weeks (long-term) with 26 HT, 24 supportive therapy, and 29 medical treatment patients completing all phases of the study. QOL was measured as a secondary outcome. Results: Short-term symptom scores improved more in the HT group (median, 59%) than in the supportive (41%; P = 0.01) or medical treatment (33%; P = 0.057) groups. HT also benefited QOL (42%) compared with either supportive therapy (10% [P < 0.001]) or medical treatment (11% [P < 0.001]). Long-term, HT significantly improved symptoms (73%) compared with supportive therapy (34% [P < 0.02]) or medical treatment (43% [P < 0.01]). QOL improved significantly more with HT (44%) than with medical treatment (20% [P < 0.001]). QOL did improve in the supportive therapy (43%) group, but 5 of these patients commenced taking antidepressants during follow-up. A total of 90% of the patients in the medical treatment group and 82% of the patients in the supportive therapy group commenced medication during follow-up, whereas none in the HT group did so (P < 0.001). Those in the HT group visited their general practitioner or gastroenterologist significantly less (median, 1) than did those in the supportive therapy (median, 4) and medical treatment (median, 4) groups during follow-up (P < 0.001). Conclusions: HT is highly effective in the long-term management of FD. Furthermore, the dramatic reduction in medication use and consultation rate provide major economic advantages.

GASTROENTEROLOGY 2002;123:1778-1785

Abbreviations:  FD , functional dyspepsia, HAD , hospital anxiety and depression, HT , hypnotherapy, IBS , irritable bowel syndrome, QOL , quality of life

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address requests for reprints to: Peter J. Whorwell, M.D., Department of Medicine, Education and Research Centre, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, United Kingdom. e-mail: peter.whorwell@smuht.nwest.nhs.uk; fax: (44) 161-434-5194.

☆☆ Supported by a grant from the Wellcome Trust.

PII: S0016-5085(02)00449-3

doi:10.1053/gast.2002.37071

Refers to article:

  • The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders

    Olafur S. Palsson, William E. Whitehead
    Gastroenterology December 2002 (Vol. 123, Issue 6, Pages 2132-2135)

Gastroenterology
Volume 123, Issue 6 , Pages 1778-1785, December 2002